

Spinal Cord Stimulation Restores Neural Function in SMA Patients
A groundbreaking clinical trial has demonstrated that spinal cord stimulation can help restore motor function in patients with spinal muscle atrophy (SMA), a severe neurodegenerative disease. Researchers at the University of Pittsburgh found that this drug-free, minimally invasive therapy improves muscle strength, walking ability, and fatigue levels, offering a new hope for treating neurodegenerative conditions.
Spinal Cord Stimulation: A New Approach to SMA Treatment
SMA is a genetic disorder that causes progressive loss of motor neurons, leading to severe muscle weakness and movement impairments. Current treatments, including gene therapy and medications, focus on slowing disease progression but do not reverse damage to nerve cells.
In this new study, researchers used spinalcord electrical stimulation to reactivate silent motor neurons, essentially rewiring neural connections to improve mobility and muscle function.
“To counteract neurodegeneration, we need two things—stop neuron death and restore function of surviving neurons,” said Dr. Marco Capogrosso, study co-author.
Clinical Trial Results: A Life-Changing Breakthrough
Three SMA patients participated in a 29-day pilot trial, undergoing spinalcord stimulation five times a week. The results were remarkable:
✔ All participants showed improved motor function
✔ Increased walking endurance by at least 20 meters
✔ Reduced fatigue and improved daily activity performance
✔ Improved motoneuron electrical function and strength
“Patients don’t expect to get better over time—but that’s exactly what we saw,” said Dr. Elvira Pirondini.
This therapy offers a potential alternative for other neurodegenerative diseases, including ALS and Huntington’s disease, by stimulating damaged neural pathways to restore movement.
Future Prospects: Expanding the Treatment
With encouraging early results, researchers plan to launch larger clinical trials to determine the long-term effectiveness of this approach. If successful, spinal cord stimulation could redefine treatment strategies for neurodegenerative diseases, providing millions of patients with renewed mobility and hope.
More Information: First-in-human study of epidural spinal cord stimulation in individuals with spinal muscular atrophy, Nature Medicine (2025). DOI: 10.1038/s41591-024-03484-8.
more recommended stories
Lactation Metabolism: Brain-Hormone Link Uncovered
Understanding how the body adjusts to.
Quantum Technology in Cancer Surgery: New Probe Aims to Improve Outcomes
A groundbreaking project from the University.
Bean-Based Gum Offers New Approach to Combat Influenza and Herpes
In an era where infectious diseases.
Shingles Vaccine May Cut Dementia Risk by 20%
A new study shows that the.
New Study Questions Fluid Restriction in Heart Failure Management
A groundbreaking study presented at the.
Role of Leptin Signaling in the DMH for Metabolic Regulation
A groundbreaking study from the Pennington.
COVID-19 Vaccines May Lower the Risk of Long COVID by 27%
A recent rapid review suggests that.
3D-Printed Hydrogel for Meniscus Tear Treatment
Meniscus tears are one of the.
Machine Learning Predicts Early Mortality in IBD Patients
A groundbreaking study published in the.
Endometriosis Treatment Advances: Latest Research and Therapy
Recent endometriosis treatment advances are reshaping.
Leave a Comment